Edition:
United Kingdom

Healthcare Headlines

FDA approves AbbVie's new rheumatoid arthritis drug

The U.S. Food and Drug Administration on Friday approved AbbVie Inc's new treatment for rheumatoid arthritis, a win for the drugmaker seeking to widen its portfolio as its blockbuster flagship therapy Humira faces competition.

Business Video

Top News